Skip to Content

Algernon Pharmaceuticals Inc A - Stock Quote AGN

Rating as of

Morningstar's Algernon Pharmaceuticals Inc A Stock Analysis

Valuation
Currency in CAD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - AGN

Algernon Pharmaceuticals Inc A's Company Profile

Business Description

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is highly capital efficient and strives to deliver maximum shareholder value. Algernon's unique approach to drug discovery is based on the concept of drug repurposing.

Contact
700 West Pender Street, Suite 915
Vancouver, BC, V6C 1G8, Canada
T +1 604 218-6281
Industry Biotechnology
Most Recent Earnings Feb 28, 2022
Fiscal Year End Aug 31, 2022
Stock Type
Employees 1